Alphatec Holdings, Inc. (NASDAQ:ATEC) Shares Purchased by Polar Asset Management Partners Inc.

Polar Asset Management Partners Inc. lifted its holdings in Alphatec Holdings, Inc. (NASDAQ:ATEC) by 381.9% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 621,224 shares of the medical technology company’s stock after purchasing an additional 492,324 shares during the quarter. Polar Asset Management Partners Inc.’s holdings in Alphatec were worth $3,454,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the business. Van ECK Associates Corp boosted its position in shares of Alphatec by 11.8% in the 2nd quarter. Van ECK Associates Corp now owns 12,275 shares of the medical technology company’s stock worth $128,000 after purchasing an additional 1,300 shares in the last quarter. Atria Investments Inc lifted its position in Alphatec by 8.0% during the 3rd quarter. Atria Investments Inc now owns 19,609 shares of the medical technology company’s stock worth $109,000 after acquiring an additional 1,460 shares during the period. Cetera Advisors LLC lifted its position in Alphatec by 15.6% during the 1st quarter. Cetera Advisors LLC now owns 12,720 shares of the medical technology company’s stock worth $175,000 after acquiring an additional 1,720 shares during the period. Comerica Bank lifted its position in Alphatec by 64.8% during the 1st quarter. Comerica Bank now owns 6,443 shares of the medical technology company’s stock worth $89,000 after acquiring an additional 2,534 shares during the period. Finally, Entropy Technologies LP lifted its holdings in shares of Alphatec by 14.9% in the 3rd quarter. Entropy Technologies LP now owns 21,623 shares of the medical technology company’s stock valued at $120,000 after buying an additional 2,800 shares during the period. Institutional investors and hedge funds own 66.35% of the company’s stock.

Alphatec Trading Up 0.5 %

ATEC opened at $10.05 on Thursday. Alphatec Holdings, Inc. has a one year low of $4.88 and a one year high of $17.34. The stock has a market capitalization of $1.43 billion, a PE ratio of -7.85 and a beta of 1.38. The business’s 50 day moving average price is $7.38 and its 200 day moving average price is $8.18. The company has a debt-to-equity ratio of 30.21, a quick ratio of 1.15 and a current ratio of 2.32.

Wall Street Analysts Forecast Growth

ATEC has been the subject of several analyst reports. Lake Street Capital decreased their price objective on Alphatec from $32.00 to $18.00 and set a “buy” rating for the company in a report on Tuesday, September 3rd. HC Wainwright restated a “buy” rating and issued a $20.00 price target on shares of Alphatec in a research note on Thursday, October 31st. Barclays lifted their price target on Alphatec from $19.00 to $20.00 and gave the company an “overweight” rating in a research note on Tuesday, November 19th. Canaccord Genuity Group reiterated a “buy” rating and set a $20.00 price objective on shares of Alphatec in a research note on Friday, August 30th. Finally, Needham & Company LLC restated a “buy” rating and issued a $13.00 price target on shares of Alphatec in a research report on Thursday, October 31st. One research analyst has rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $17.11.

Alphatec Profile

Alphatec Holdings, Inc, a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems.